RECURSION PHARMACEUTICALS, INC. — Director's Dealing 2026

Feb 10, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK: 0001601830
Period of Report: 2026-02-06

Reporting Person: Taylor Ben R (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-06	Class A Common Stock	A	446279	—	Acquired	1207829	Direct
2026-02-06	Class A Common Stock	A	24254	—	Acquired	1232083	Direct
2026-02-06	Class A Common Stock	F	11400	$3.98	Disposed	1220683	Direct

Footnotes

F1: This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2026 and every three months thereafter.

F2: This RSU vested immediately upon the grant date.

F3: Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.